가정용 간헐적 카테터 장치 시장 규모, 점유율과 동향 분석 보고서 : 제품별, 사용자 카테고리별, 용도별, 첨단별, 유통 채널별, 지역별, 부문 예측(2026-2033년)

Home Use Intermittent Catheter Devices Market Summary

The global home use intermittent catheter devices market size was estimated at USD 1.74 billion in 2025 and is projected to reach USD 2.72 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033. The market is primarily driven by the rising prevalence of chronic urinary disorders and the growing elderly population requiring long-term bladder management.

A strong shift toward home-based self-care, supported by healthcare cost-containment efforts, is accelerating the adoption of self-care outside clinical settings. Technological advancements, including hydrophilic coatings, compact designs, and closed-system catheters, have enhanced safety, comfort, and ease of use for patients. In addition, increased awareness of lower infection risk compared to indwelling catheters continues to support market growth.

The rising prevalence of urological and neurological disorders such as spinal cord injuries, multiple sclerosis, urinary retention, and neurogenic bladder has significantly increased the need for long-term bladder management solutions. As many of these conditions require regular and ongoing catheterization, patients are opting for home-use intermittent catheters, which enable safe self-management, independence, and reduced reliance on clinical settings.

The rising prevalence of spinal cord injury (SCI) is driving growth in the home-use intermittent catheter device market, as many SCI patients require lifelong bladder management due to a neurogenic bladder. Increased emphasis on intermittent self-catheterization for home care, along with improved survival rates and a shift from hospital to home settings, is enhancing demand for easy-to-use intermittent catheters. For instance, according to the National Spinal Cord Injury Statistical Center, in 2024, approximately 308,620 individuals are currently living with traumatic spinal cord injury (tSCI) in the United States, with estimates ranging from 259,374 to 393,913 persons.

Home Use Intermittent Catheter Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global home use intermittent catheter devices market report based on product, user category, application, tip, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Coated Catheters (Hydrophilic)
• Uncoated Catheters
• User Category Outlook (Revenue, USD Million, 2021 - 2033)
• Male
• Female
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Urinary Incontinence (UI)
• Neurogenic Bladder
• Urinary Retention
• Post-Surgical Care
• Tip Outlook (Revenue, USD Million, 2021 - 2033)
• Straight
• Coude
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• DME / Home Care Providers
• Online Pharmacies / E-Commerce
• Retail Pharmacies
• Hospital Stores / Outpatient Clinics
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. User Category
  • 1.1.3. Application
  • 1.1.4. Tip
  • 1.1.5. Distribution Channel
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Home Use Intermittent Catheter Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of urological and neurological disorders
    • 3.2.1.2. Shift toward home-based self-care management
    • 3.2.1.3. Product innovations improving safety and comfort
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of advanced catheter products
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growth of hydrophilic and closed-system catheter adoption
    • 3.2.3.2. Supportive reimbursement and policy developments
    • 3.2.3.3. Untapped potential in emerging markets
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Risk of urinary tract infections and complications
    • 3.2.4.2. Limited patient awareness and training barriers
• 3.3. Home Use Intermittent Catheter Devices Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Home Use Intermittent Catheter Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Home Use Intermittent Catheter Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Home Use Intermittent Catheter Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.3.1. Coated Catheters (Hydrophilic)
    • 4.3.1.1. Coated catheters (Hydrophilic) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Uncoated Catheters
    • 4.3.2.1. Uncoated catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Home Use Intermittent Catheter Devices Market: User Category Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Home Use Intermittent Catheter Devices Market: User Category Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Home Use Intermittent Catheter Devices Market Size & Trend Analysis, by User Category, 2021 to 2033 (USD Million)
  • 5.3.1. Male
    • 5.3.1.1. Male market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Female
    • 5.3.2.1. Female market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Home Use Intermittent Catheter Devices Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Home Use Intermittent Catheter Devices Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Home Use Intermittent Catheter Devices Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.3.1. Urinary Incontinence (UI)
    • 6.3.1.1. Urinary incontinence (UI) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Neurogenic Bladder
    • 6.3.2.1. Neurogenic bladder market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Urinary Retention
    • 6.3.3.1. Urinary retention market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Post-Surgical Care
    • 6.3.4.1. Post-surgical care market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Home Use Intermittent Catheter Devices Market: Tip Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Home Use Intermittent Catheter Devices Market: Tip Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Home Use Intermittent Catheter Devices Market Size & Trend Analysis, by Tip, 2021 to 2033 (USD Million)
  • 7.3.1. Straight
    • 7.3.1.1. Straight market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Coude
    • 7.3.2.1. Coude market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Home Use Intermittent Catheter Devices Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Home Use Intermittent Catheter Devices Market: Distribution Channel Movement Analysis, 2025 & 2033 (USD Million)
• 8.3. Global Home Use Intermittent Catheter Devices Market Size & Trend Analysis, by Distribution Channel 2021 to 2033 (USD Million)
  • 8.3.1. DME / Home Care Providers
    • 8.3.1.1. DME / home care Providers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. Online Pharmacies / E-Commerce
    • 8.3.2.1. Online pharmacies / e-commerce market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Retail Pharmacies
    • 8.3.3.1. Retail pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Hospital Stores / Outpatient Clinics
    • 8.3.4.1. Hospital stores / outpatient clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Home Use Intermittent Catheter Devices Market: Regional Estimates & Trend Analysis by Product, User Category, Application, Tip and Distribution Channel

• 9.1. Regional Dashboard
• 9.2. Market Size and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. UK home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. Germany home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. France home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Italy home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Spain home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Denmark home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Competitive scenario
    • 9.4.9.3. Regulatory framework
    • 9.4.9.4. Reimbursement scenario
    • 9.4.9.5. Norway home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. China home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. Japan
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. Japan home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. India home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. South Korea home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Australia home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Reimbursement scenario
    • 9.5.7.5. Thailand home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Brazil home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Argentina home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. Middle East and Africa
  • 9.7.1. Middle East and Africa home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. South Africa home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. Saudi Arabia home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. UAE home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. Kuwait home use intermittent catheter devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis, 2025
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Product Launches
  • 10.5.5. Research And Development
  • 10.5.6. Company Profiles
  • 10.5.7. Teleflex Incorporated
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Coloplast Corp
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Wellspect HealthCare, a Dentsply Sirona Company
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. HR HealthCare
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. BD
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product Benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Hollister Incorporated
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product Benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. B. Braun SE
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product Benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. Amsino International, Inc.
    • 10.5.14.1. Company overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product Benchmarking
    • 10.5.14.4. Strategic initiatives
  • 10.5.15. Otsuka Pharmaceutical Factory, Inc.
    • 10.5.15.1. Company overview
    • 10.5.15.2. Financial performance
    • 10.5.15.3. Product Benchmarking
    • 10.5.15.4. Strategic initiatives
  • 10.5.16. Cardinal Health
    • 10.5.16.1. Company overview
    • 10.5.16.2. Financial performance
    • 10.5.16.3. Product Benchmarking
    • 10.5.16.4. Strategic initiatives
  • 10.5.17. Convatec
    • 10.5.17.1. Company overview
    • 10.5.17.2. Financial performance
    • 10.5.17.3. Product Benchmarking
    • 10.5.17.4. Strategic initiatives
  • 10.5.18. Medline
    • 10.5.18.1. Company overview
    • 10.5.18.2. Financial performance
    • 10.5.18.3. Product Benchmarking
    • 10.5.18.4. Strategic initiatives